Page 44 - 2020_01-Haematologica-web
P. 44

E. Mejia-Ramirez and M.C. Florian et al.
Perspectives for rejuvenation and therapeutic strategies
In this review, we have summarized some of the most recent and relevant information about the intrinsic fac- tors that affect HSC upon aging. In general, we can iden- tify at least five biological processes, which we would define as intrinsic HSC aging mechanisms (Table 1 and Figure 4). DNA damage, metabolism, epigenetics/chro- matin architecture, proteostasis, and signaling. However, the cell cannot compartmentalize hermetically each one of these processes. This is the reason why the intercon- nections between these biological processes will be a key aspect in deciphering the extent of the impact of aging on HSC. For instance, the levels of several metabolites like SAM or ketoglutharate affect the activity of methy- lases, which in turn have an effect on the epigenetics of the cell.35 Investigating and understanding cellular and molecular mechanisms of HSC aging will increase the
possibility of defining new pharmacological targets to reduce the negative effects of aging and promote “healthy aging”.
We are aware that most aging mechanisms that we have reviewed here have been studied in the murine or in non- human systems. Nevertheless, we would like to empha- size the progress achieved so far and the importance of pursuing an integrative research approach, to connect all the aspects affecting stem cell aging. A broader view of this process might indeed be central in bridging the gap to translation in the human system.
Acknowledgment
This work was supported by the Deutsche Forschungsgemeinschaft (DFG or German Research Foundation) FOR2674 and SFB1074 to MCF and by Ministerio de Ciencia, Innovación y Universidades (Spanish Ministry of Science, Innovation and University) PGC2018-102049-B-I00 and RYC2018-025979-I to MCF.
References
1. Klepin HD. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly. Clin Geriatr Med. 2016;32(1):155-173.
2. Akunuru S, Geiger H. Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells. Trends Mol Med. 2016;22(8):701-712.
3. Preussler JM, Meyer CL, Mau LW, et al. Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2017;23(6):1021-1028.
4. Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11(3):275-286.
5. Chandel NS, Jasper H, Ho TT, Passegue E. Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing. Nat Cell Biol. 2016;18(8):823-832.
6. Singh AK, Althoff MJ, Cancelas JA. Signaling Pathways Regulating Hematopoietic Stem Cell and Progenitor Aging. Current Stem Cell Rep. 2018;4(2):166-181.
7. Rossi DJ, Bryder D, Zahn JM, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. 2005;102(26):9194-9199.
8. Sudo K, Ema H, Morita Y, Nakauchi H. Age- Associated Characteristics of Murine Hematopoietic Stem Cells. J Exp Med. 2000;192(9):1273-1280.
9. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. 2011;108(50):20012-20017.
10. Vas V, Senger K, Dorr K, Niebel A, Geiger H. Aging of the microenvironment influences clonality in hematopoiesis. PLoS One. 2012;7(8):e42080.
11. Ergen AV, Boles NC, Goodell MA. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood. 2012;119(11):2500-2509.
12. Guidi N, Sacma M, Standker L, et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 2017;36(7):840-853.
13. Beerman I, Maloney WJ, Weissmann IL, Rossi DJ. Stem cells and the aging hematopoietic system. Curr Opin Immunol. 2010;22(4):500-506.
14. Florian MC, Dorr K, Niebel A, et al. Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell. 2012;10(5):520-530.
15. Florian MC, Klose M, Sacma M, et al. Aging alters the epigenetic asymmetry of HSC division. PLoS Biol. 2018;16(9):e2003389.
16. Signer RA, Montecino-Rodriguez E, Witte ON, McLaughlin J, Dorshkind K. Age-relat- ed defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood. 2007;110(6):1831-1839.
17. Yamamoto R, Wilkinson AC, Ooehara J, et al. Large-Scale Clonal Analysis Resolves Aging of the Mouse Hematopoietic Stem Cell Compartment. Cell Stem Cell. 2018;22(4):600-607.
syndromes. Blood. 2015;126(1):9-16.
25. Jaiswal S, Natarajan P, Silver AJ, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med.
2017;377(2):111-121.
26. Yu VWC, Yusuf RZ, Oki T, et al. Epigenetic
Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells. Cell. 2016;167(5):1310-1322.
27. Beerman I, Bock C, Garrison BS, et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell. 2013;12(4):413-425.
28. Sun D, Luo M, Jeong M, et al. Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal. Cell Stem Cell. 2014;14(5):673-688.
29. Grigoryan A, Guidi N, Senger K, et al. LaminA/C regulates epigenetic and chro- matin architecture changes upon aging of hematopoietic stem cells. Genome Biol. 2018;19(1):189.
30. Maryanovich M, Zahalka AH, Pierce H, et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat Med. 2018;24(6):782-
18. Mann M, Mehta A, de Boer CG, et al. Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory
Stimuli Are Altered with Age. Cell Rep. 791.
2018;25(11):2992-3005.
19. Lopez-Otin C, Blasco MA, Partridge L,
Serrano M, Kroemer G. The hallmarks of
aging. Cell. 2013;153(6):1194-1217.
20. Beerman I, Seita J, Inlay MA, Weissman IL, Rossi DJ. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle.
Cell Stem Cell. 2014;15(1):37-50.
21. Flach J, Bakker ST, Mohrin M, et al. Replication stress is a potent driver of func- tional decline in ageing haematopoietic
stem cells. Nature. 2014;512(7513):198-202. 22. Akunuru S, Geiger H. Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells.
Trends Mol Med. 2016;22(8):701-712.
23. Chen J, Kao YR, Sun D, et al. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell
level. Nat Med. 2019;25(1):103-110.
24. Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic
31. Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol. 2014;15(4):243-256.
32. Verovskaya EV, Dellorusso PV, Passegué E. Losing Sense of Self and Surroundings: Hematopoietic Stem Cell Aging and Leukemic Transformation. Trends Mol Med. 2019;25(6):494-515.
33. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67-93.
34. Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018;19(6):365-381.
35. Ho TT, Warr MR, Adelman ER, et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature. 2017;543(7644):205-210.
36. Vilchez D, Simic MS, Dillin A. Proteostasis and aging of stem cells. Trends Cell Biol. 2014;24(3):161-170.
37. Noormohammadi A, Calculli G, Gutierrez- Garcia R, Khodakarami A, Koyuncu S,
34
haematologica | 2020; 105(1)


































































































   42   43   44   45   46